Researchers
Ružić, Dušan
Results 1-20 of 91
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Novel 1-benzhydryl piperazine scaffoldbased HDAC inhibitor b7 induces synergistic antiproliferative effect with vemurafenib in colorectal cancer cells harboring BRAF mutation![]() | Vuletić, Ana | Conference Paper | Mp. category will be shown later |
| 2025 | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents![]() | Beljkaš, Milan | Article | 22M22 |
| 2025 | A computational framework for the design and development of ERK2 and multi-target ERK2/HDAC inhibitors![]() | Cebzan, Alen; Ružić, Dušan | Article | 21M21 |
| 2025 | P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular Modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2025 | Application of Separation Methods in Biomimetic Studies and the Determination of Physicochemical Properties of Imidazoline and αAdrenergic Receptor Ligands![]() | Oljacic, Slavica | Conference Paper | Mp. category will be shown later |
| 2025 | Towards a pan-HDAC chemoproteomics drug profiling assay | Dimitriadou, Aspasia; Lechner, Severin; Sarnari, Chiara; Radović, Branko | Conference Paper | Mp. category will be shown later |
| 2025 | Exploring the effect of bioenvironment on the ionization of drugs using the membrane mimetic properties of differently charged micelles | Popović-Nikolić, Marija | Conference Paper | Mp. category will be shown later |
| 2025 | A pan-HDAC chemoproteomics assay to profile drugs | Dimitriadou, Aspasia; Lechner, Severin; Sarnari, Chiara; Radović, Branko | Conference Paper | Mp. category will be shown later |
| 2025 | Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitors | Borrello, Maria Teresa; Ruzic, Dusan | Article | 21M21 |
| 2024 | Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatment![]() | Beljkaš, Milan | Conference Paper | Mp. category will be shown later |
| 2024 | Integrative Framework for Developing Innovative SIRT2 Inhibitors![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2024 | Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2024 | Targeting noncoding RNAs to treat atherosclerosis![]() | Sopić, Miron | Article | 21a+M21a+ |
| 2023 | Screening of naphthalimides as antimetastatic agents | Sánchez-Martín, Victoria; Ružić, Dušan
García-Salcedo, Jose Antonio;
| Conference Paper | Mp. category will be shown later |
| 2023 | Discovery of novel HDAC inhibitors for therapy of triple-negative breast cancer – preclinical study![]() | Ružić, Dušan | Conference Paper | Mp. category will be shown later |
| 2023 | Computer-aided drug design of MAPK inhibitors by combined 3D-QSAR analysis and molecular docking![]() | Čebzan, Alen | Conference Paper | Mp. category will be shown later |
| 2023 | Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer![]() | Beljkas, Milan | Article | 21aM21a |
| 2023 | Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinoma![]() | Nemanja Djokovic | Article | 21M21 |
| 2023 | Discovery of novel small molecule inhibitors of HDAC6 that suppress liver fibrosis | Borrello, Maria Teresa; Ružić, Dušan | Conference Paper | Mp. category will be shown later |
| 2023 | Towards the multitarget HDAC Inhibitors for the treatment of pancreatic carcinoma by joining the drug synergy predictions and the molecular modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
